1. Broderick D. Técnicas de neuroimagen en neuropsiquiatría.
Clínicas psiquiátricas de Norteamérica. 2005, vol. 28, pp. 549-566.
2.
Wee-Chung A, Hong Y. Current methods in the automatic tissue segmentation of 3D
magnetic resonance brain images. Current
Medical Imaging Reviews. 2006, vol. 2, n. 1.
3. Fischl B. FreeSurfer. Neuroimage. 2012:
62(2): 774"“781.
4. Geda Y. Mild Cognitive Impairment in Older Adults.
Curr Psychiatry Rep. 2012;14(4):320-327.
5. Barnes D, Yaffe K. The projected
effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011;10:819-28.
6. Prince M, Wimo A, Guerchet M, Ali G, Wu Y, Prina M, et al. World Alzheimer Report 2015. The
Global Impact of Dementia: an analysis of prevalence, incidence, cost and
trends. Disponible en: http://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf
7. Forlenza O, Diniz B, Stella F,
Teixeira A, Gattaz W. Mild cognitive impairment (part 2): diagnosis and
prediction of dementia in Alzheimer"™s disease. Rev Bras Psiquiatr.
2013;(35):284-294.
8. Blatter D, Bigler E, Gale S, Johnson S, Anderson C,
Burnett B, Parker N, Kurth S, Horn S. Quantitative
Volumetric Analysis of Brain MR: Normative Database Spanning 5 Decades of Life.
American Journal of
Neuroradiology. 1995, vol.16, pp. 241"“251.
9. Elshafey R, Hassanien O, Khalil M, Allah M, Saad S,
Baghdadi M, El Zayady M. Hippocampus, caudate nucleus and entorhinal cortex
volumetric MRI measurements in discrimination between Alzheimer"™s disease, mild
cognitive impairment, and normal aging. The Egyptian Journal of Radiology and
Nuclear Medicine. 2014, vol. 45, pp. 511"“518.
10. Insausti R, Juottonen K, Soininen H, Insausti A,
Partanen K, Vainio P, Laakso M, Pitkanen A. MR Volumetric Analysis of the Human Entorhinal, Perirhinal, and
Temporopolar Cortices. American
Journal of Neuroradiology. 1998, vol. 19, pp.659 "“671.
11. Varon D, Loewenstein D, Potter E, Greig M, Agron
J, Shen Q, et al. Minimal atrophy of the entorhinal cortex and hippocampus:
progression of cognitive impairment. Dementia and Geriatric Cognitive Disorders.
2011, vol. 31, pp. 276"“283.
12. Suphaphong S, Tritanon O,
Laothamatas J, Sungkarat W. MRI volumetry of hippocampus and amygdala in normal
aging, mild cognitive impairment and Alzheimer"™s disease subjects. Ramathibodi
Hospital, Mahidol University. Bangkok, Thailand.
13. Zarei M, Patenaude B, Damoiseaux J, Morgese C, Smith
S, Matthews P, Barkhof F, Rombouts S, Sanz-Arigita E, Jenkinson M. Combining
shape and connectivity analysis: An MRI study of thalamic degeneration in
Alzheimer's disease. NeuroImage. 2010, vol. 49, pp. 1"“8.
14. Jong L, Hiele K, Veer M, Houwing J, Westendorp R, Bollen E, de Bruin P,
Middelkoop H, van Buchem A, van der Grond J. Strongly reduced volumes of putamen
and thalamus in Alzheimer"™s disease: an MRI study. Brain. 2008, vol. 131, pp. 3277-3285.
15. Moretti D, Paternico D, Binetti G,
Zanetti O, Frisoni G. Analysis of grey matter in thalamus and basal ganglia
based on EEG a3/a2 frequency ratio reveals specific changes in subjects with
mild cognitive impairment. ASN NEURO. 2012, n. 4, vol. 7.
16. Keller S, Gerdes J, Mohammadi S, Kellinghaus C, Kugel H, Deppe K, Ringelstein E, Evers S, Schwindt W, Deppe M.
Volume Estimation of the Thalamus Using Freesurfer and Stereology: Consistency
between Methods. Neuroinform. 2012, vol. 10, pp.341"“350.
